Our upcoming webinar, Address Unmet Measurement Needs in Parkinson’s Disease with Wearable DHTs, will be held live on 7/29! Click here to register: https://hubs.la/Q02GL1sc0 Fatta B. Nahab MD, FAAN, FANA from Neuron23 and Karen Krygier, MBA from PKG Health will join Christine Cong Guo to discuss these key topics - 📋Understanding the cardinal symptoms of Parkinson’s disease 📐 The limitations of existing clinical scales 📈 Research efforts in leveraging wearable DHTs 🚶♂️ Clinically validated algorithms that use wearable DHT data to characterize PD symptoms #DigitalHealthMonthly #ParkinsonsDisease #Neurology #Wearables #DHTs #ClinicalTrials
ActiGraph
Biotechnology Research
Pensacola, FL 4,885 followers
Pioneering the digital transformation of clinical research
About us
ActiGraph is pioneering the digital transformation of clinical research. We provide end-to-end digital health technology (DHT) solutions by integrating and operationalizing the best wearables, software, and algorithms to generate reliable evidence and get the right treatments to the right patients, faster. ActiGraph’s medical-grade wearable technology platform has been used to capture real-world, continuous digital measures of sleep, activity, and mobility for nearly 250 industry-sponsored clinical trials and thousands of academic research and public health studies. Appearing in over 23,000 published scientific papers to date, ActiGraph is the most experienced and trusted wearable technology partner in the industry.
- Website
-
http://www.theactigraph.com/
External link for ActiGraph
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Pensacola, FL
- Type
- Privately Held
- Founded
- 2004
Locations
-
Primary
49 East Chase Street
Pensacola, FL 32502, US
Employees at ActiGraph
Updates
-
Outsourcing-Pharma's Liza Laws talks with ActiGraph’s CSO Christine Cong Guo about the transformative potential of wearables in providing accurate, real-world sleep data 💤 Check out the full article to learn more about how this type of data can improve patient outcomes ⏩ https://hubs.la/Q02GyrfG0 #Wearable #SleepData #ClinicalTrials #PatientCentricity
-
🔀 We're excited to announce the integration of Mobilise-D algorithms for digital mobility outcomes into ActiGraph's CentrePoint Cloud Platform! Click here to read more 🔷 https://hubs.la/Q02GggwT0 During the multi-year Mobilise-D project, 🏃 mobility data in healthy and disease populations were collected with wearable DHTs to generate validated digital mobility measures to advance research in this important area of health. 🔬 Researchers can now incorporate these measures into their study using the most up-to-date and clinically validated Mobilise-D algorithms supported by ActiGraph’s state-of-the-art wearable device hardware and innovative software platform. #Wearables #Mobility #Gait #DigitalMeasures #MobiliseD #ActiGraph
ActiGraph Announces Integration of Mobilise-D Algorithms in CentrePoint Platform
blog.theactigraph.com
-
🔦 The recent success of GLP-1 receptor agonists drugs in achieving weight loss has put obesity into the spotlight as a chronic disease that requires comprehensive management. Despite initial positive outcomes, the long-term benefits of these obesity treatments are still under scrutiny. 🔎 In our latest white paper, we dive into some of the open questions related to new obesity treatments, and discuss future opportunities for drug developers to provide more targeted and effective treatments for patients by - 🎯 developing evidence-based guidelines for the physical activity that accompanies pharmaceutical treatments 🎯 capturing low-burden and objective assessments of physical function and sleep quality that are often negatively impacted by obesity Read more here 📒 https://hubs.la/Q02G3Nm_0 #Obesity #PhysicalActivity #Sleep #DrugDevelopment
-
-
🎥 Our live Digital Health Monthly scientific webinar on July 29th will focus on how to Address Unmet Measurement Needs in Parkinson’s Disease with Wearable DHTs. Register here ➡️ https://hubs.la/Q02FPX5w0 Christine Cong Guo will be joined by Fatta B. Nahab MD, FAAN, FANA from Neuron23 and Karen Krygier, MBA from PKG Health to review the unique challenges researchers and drug developers face when studying Parkinson's disease. The group will discuss the current state-of-the-art wearable DHT solutions and how they can help overcome challenges to advance treatments for this group of patients. We hope you can join the conversation! #ParkinsonsDisease #Neurology #MovementDisorders #DHT #Wearables #DigitalHealthMonthly
-
-
🔍 DHTs bring many potential benefits to clinical research, but there are still technical challenges to overcome for DHTs to be used in research across populations, including pediatric participants. 🏃♂️ During a recent session of Digital Health Monthly, Junrui Di joined Rakesh Pilkar to review the results of the study, Measuring Activity and Gait in Children with DHTs, and shed light on the intricacies of this project. 📔 Read the recap here: https://hubs.la/Q02F26Zm0 #DigitalHealthMonthly #DHT #PediatricResearch #ClinicalResearch
Measuring Activity and Gait in Children with DHTs
blog.theactigraph.com
-
Couldn’t join us for this week’s Digital Health Monthly webinar? No problem! DHT 101 for Clinical Research is now available on-demand. 🎬 https://hubs.la/Q02DBNTr0 Watch now to learn more about the use of wearable-derived data as endpoints in clinical trials, addressing important points along the journey including - ☑️ The definition of DHT ☑️ Common uses in regulated trials ☑️ Key validation evidence ☑️ Operational deployment considerations #DigitalHealthMonthly #DHT #ClinicalTrials #Regulatory #Validation
Digital Health Monthly: DHT 101 | ActiGraph
theactigraph.com
-
Don't miss out! There is still time to register for and join the public meeting, co-led by FDA and Digital Medicine Society (DiMe), sharing insights to support the use of patient-generated health data in medical device development 👉 https://lnkd.in/ej93__-2 We are delighted to be part of this impressive agenda and hope you can join the conversation! 🔷 6/26, 11:30am ET, Jeremy Wyatt will participate in the keynote panel discussion, Vision: 2023: Advancing Clinical Research with Patient-Generated Health Data 🔷 6/27, 1:00pm ET, Christine Cong Guo will present in the session, From Rarity to Clarity: PGHD's Role in Rare Diseases, to share key lessons learned around digital endpoint development #patientcentricity #datacollection #clinicaltrials
🚨🚨🚨 Last call to register! Our FREE public meeting led by FDA and the Digital Medicine Society (DiMe) starts tomorrow! Join us on June 26 and June 27, from 11 a.m. to 3 p.m. ET each day. We’ll explore how patient-generated health data (PGHD) can advance remote clinical trial #data collection and facilitate high-quality clinical outcome assessment. 👥 During this 2-day public meeting, you will have the opportunity to learn about and discuss: ▪️ How to implement PGHD throughout the total product life cycle development of medical device development ▪️ Tangible case examples of how PGHD has informed medical devices and can improve return on investment ▪️ How PGHD can help improve health equity by promoting inclusivity in research studies ▪️ Case-based learning on the use of PGHD for medical device developers, scientists, and patients 🔗 Register today and join us for this unique opportunity to learn alongside industry leaders and contribute to future work on resources to advance the use of PGHD in clinical research and regulatory science. https://lnkd.in/ej93__-2 AbbVie ActiGraph Advanced Research Projects Agency for Health (ARPA-H) Bellerophon Therapeutics Clario COPD Foundation Empatica Evidation FasterCures FDA Google HITea With Grace Jackson Heart Study, Koneksa Medable, Inc The Michael J. Fox Foundation for Parkinson's Research National Organization for Rare Disorders Netherlands Organisation for Applied Scientific Research TNO The Light Collective Tidepool Verily VivoSense, Inc. Walgreens Boots Alliance White House Office of Science and Technology Policy WHOOP
Using PGHD in medical device development – Digital Medicine Society (DiMe)
https://dimesociety.org
-
🙏 Thank you to everyone who visited us at #ICAMPAM2024! It was inspiring to connect with experts in ambulatory monitoring and movement tracking. Let's continue to innovate and improve health outcomes together! Let’s reconnect: https://hubs.la/Q02D2yv30 #ICAMPAM2024 #AmbulatoryMonitoring #ActiGraph
-
-
The life sciences community faces many challenges. But after DIA 2024, it’s equally evident that collaborative efforts are yielding solutions. Over the last several days, we’ve had the opportunity to share more about the impact of our digital health technologies in clinical research and the pleasure of connecting with so many people working hard to make a difference. Together, we will continue to enhance healthcare around the world. 💙 #DIA2024 #LifeSciences #DigitalHealthTechnologies #DHT #ActiGraph
-